Oncotelic Therapeutics, Inc. Accounts Payable and Other Accrued Liabilities, Current
Oncotelic Therapeutics, Inc. (OTLC) had Accounts Payable and Other Accrued Liabilities, Current of $2.44 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2023-11-14
- 2023-09-30: Accounts Payable and Other Accrued Liabilities, Current $2.44M.
- 2023-06-30: Accounts Payable and Other Accrued Liabilities, Current $2.46M.
- 2023-03-31: Accounts Payable and Other Accrued Liabilities, Current $2.55M.
- 2022-12-31: Accounts Payable and Other Accrued Liabilities, Current $2.51M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2023-09-30 | $2.44M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.46M 10-Q · filed 2023-08-18 |
| 2023-03-31 | $2.55M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $2.51M 10-Q · filed 2023-11-14 |